High Fibrosis-4 is Associated With Increased Risk of Cirrhosis Decompensation and Liver-Related Mortality in at-Risk Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease

Saved in:
Bibliographic Details
Main Authors: Elizabeth E. Powell, Gunter Hartel, Katharine M. Irvine, James O’Beirne, Vikas Bhasker, Patricia C. Valery
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Gastro Hep Advances
Online Access:http://www.sciencedirect.com/science/article/pii/S2772572324002036
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849325078688301056
author Elizabeth E. Powell
Gunter Hartel
Katharine M. Irvine
James O’Beirne
Vikas Bhasker
Patricia C. Valery
author_facet Elizabeth E. Powell
Gunter Hartel
Katharine M. Irvine
James O’Beirne
Vikas Bhasker
Patricia C. Valery
author_sort Elizabeth E. Powell
collection DOAJ
format Article
id doaj-art-1056a4d539e14c2999375ef08f2d4ca8
institution Kabale University
issn 2772-5723
language English
publishDate 2025-01-01
publisher Elsevier
record_format Article
series Gastro Hep Advances
spelling doaj-art-1056a4d539e14c2999375ef08f2d4ca82025-08-20T03:48:31ZengElsevierGastro Hep Advances2772-57232025-01-014410060710.1016/j.gastha.2024.100607High Fibrosis-4 is Associated With Increased Risk of Cirrhosis Decompensation and Liver-Related Mortality in at-Risk Patients With Metabolic Dysfunction–Associated Steatotic Liver DiseaseElizabeth E. Powell0Gunter Hartel1Katharine M. Irvine2James O’Beirne3Vikas Bhasker4Patricia C. Valery5Department of Gastroenterology and Hepatology, Princess Alexandra Hospital, Brisbane, Queensland, Australia; Faculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia; QIMR Berghofer Medical Research Institute, Herston, Queensland, AustraliaQIMR Berghofer Medical Research Institute, Herston, Queensland, AustraliaMater Research, Translational Research Institute, Brisbane, Queensland, AustraliaSunshine Coast University Hospital, Sunshine Coast, Queensland, AustraliaDepartment of Gastroenterology and Hepatology, Princess Alexandra Hospital, Brisbane, Queensland, Australia; QIMR Berghofer Medical Research Institute, Herston, Queensland, AustraliaFaculty of Medicine, The University of Queensland, Brisbane, Queensland, Australia; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia; Correspondence: Address correspondence to: Patricia C. Valery, MD, MPH, PhD, Cancer & Chronic Disease Research Group, QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, Queensland 4006, Australia.http://www.sciencedirect.com/science/article/pii/S2772572324002036
spellingShingle Elizabeth E. Powell
Gunter Hartel
Katharine M. Irvine
James O’Beirne
Vikas Bhasker
Patricia C. Valery
High Fibrosis-4 is Associated With Increased Risk of Cirrhosis Decompensation and Liver-Related Mortality in at-Risk Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease
Gastro Hep Advances
title High Fibrosis-4 is Associated With Increased Risk of Cirrhosis Decompensation and Liver-Related Mortality in at-Risk Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease
title_full High Fibrosis-4 is Associated With Increased Risk of Cirrhosis Decompensation and Liver-Related Mortality in at-Risk Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease
title_fullStr High Fibrosis-4 is Associated With Increased Risk of Cirrhosis Decompensation and Liver-Related Mortality in at-Risk Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease
title_full_unstemmed High Fibrosis-4 is Associated With Increased Risk of Cirrhosis Decompensation and Liver-Related Mortality in at-Risk Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease
title_short High Fibrosis-4 is Associated With Increased Risk of Cirrhosis Decompensation and Liver-Related Mortality in at-Risk Patients With Metabolic Dysfunction–Associated Steatotic Liver Disease
title_sort high fibrosis 4 is associated with increased risk of cirrhosis decompensation and liver related mortality in at risk patients with metabolic dysfunction associated steatotic liver disease
url http://www.sciencedirect.com/science/article/pii/S2772572324002036
work_keys_str_mv AT elizabethepowell highfibrosis4isassociatedwithincreasedriskofcirrhosisdecompensationandliverrelatedmortalityinatriskpatientswithmetabolicdysfunctionassociatedsteatoticliverdisease
AT gunterhartel highfibrosis4isassociatedwithincreasedriskofcirrhosisdecompensationandliverrelatedmortalityinatriskpatientswithmetabolicdysfunctionassociatedsteatoticliverdisease
AT katharinemirvine highfibrosis4isassociatedwithincreasedriskofcirrhosisdecompensationandliverrelatedmortalityinatriskpatientswithmetabolicdysfunctionassociatedsteatoticliverdisease
AT jamesobeirne highfibrosis4isassociatedwithincreasedriskofcirrhosisdecompensationandliverrelatedmortalityinatriskpatientswithmetabolicdysfunctionassociatedsteatoticliverdisease
AT vikasbhasker highfibrosis4isassociatedwithincreasedriskofcirrhosisdecompensationandliverrelatedmortalityinatriskpatientswithmetabolicdysfunctionassociatedsteatoticliverdisease
AT patriciacvalery highfibrosis4isassociatedwithincreasedriskofcirrhosisdecompensationandliverrelatedmortalityinatriskpatientswithmetabolicdysfunctionassociatedsteatoticliverdisease